Recurrent Lip and Oral Cavity Carcinoma
1 clinical trials · Condition
◉ Watch Recurrent Lip and Oral Cavity Carcinoma
| Record | Firm | Date |
|---|---|---|
| Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors (NCT03420963) | M.D. Anderson Cancer Center | 2018-08-31 |
Track Recurrent Lip and Oral Cavity Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.